ISSN: 2584-2781
About the Journal
International journal of Pharmaceutical and Healthcare innovation (IJPHI) is a peer-reviewed journal published quarterly. It is a peer-reviewed journal aiming to communicate high-quality original research work, reviews, short communications, case reports, Ethics forums, Education forums and Letters to the editor that contribute significantly to further the scientific knowledge related to the field of pharmaceutical sciences. International journal of Pharmaceutical and Healthcare innovation publishes Original Research Articles, Short Communications, Review Articles in all areas of pharmaceutical sciences from the discovery of a drug up to clinical evaluation. Topics covered are: Artificial intelligence machine learning innovation in Healthcare industry, Artificial intelligence ,machine learning innovation in the field of drug discovery, medicinal and analytical chemistry, Pharmaceutical chemistry, Pharmaceutics and Pharmacokinetics; including; Pharmacognosy including herbal products standardization and Phytochemistry; Pharmacology: Allied sciences including drug regulatory affairs, Pharmaceutical Marketing, Pharmaceutical Microbiology, Pharmaceutical biochemistry, Pharmaceutical Education and Hospital Pharmacy. Articles with timely interest and newer research concepts will be given more preference. All articles published in this journal represent the opinion of the authors and do not reflect the official policy of (International journal of Pharmaceutical and Healthcare innovation). All papers are subjected to double-blinded peer review.
Current Issue
The Two-Day International Conference on “Next-Generation Therapeutics: Integrating Nanotechnology with Advanced Drug Discovery Platforms” aims to bring together distinguished scientists, academicians, clinicians, pharmaceutical researchers, industry professionals, regulatory experts, and young investigators from across the globe to discuss recent advances and emerging trends in nanotechnology-enabled therapeutics and innovative drug discovery approaches.
The conference will serve as a multidisciplinary platform for exchanging knowledge, presenting cutting-edge research, fostering collaborations, and addressing current challenges in translating laboratory discoveries into clinically successful therapies.
The rapid evolution of nanotechnology, artificial intelligence (AI), machine learning, computational drug design, precision medicine, genomics, biotechnology, and advanced pharmaceutical formulations has transformed the landscape of modern therapeutics. The integration of these technologies offers unprecedented opportunities to improve drug efficacy, enhance bioavailability, achieve targeted drug delivery, minimize adverse effects, and accelerate the development of personalized medicines.
This conference seeks to explore these innovations while highlighting translational research, regulatory considerations, commercialization strategies, and future directions for next-generation healthcare.
Participants will gain valuable insights through keynote lectures, invited talks, technical sessions, poster presentations, and oral presentations led by internationally renowned experts. The conference also aims to encourage interdisciplinary collaborations between academia, healthcare institutions, research organizations, and pharmaceutical industry to develop innovative solutions for addressing global healthcare challenges.
By providing a common platform for scientific exchange, the conference will inspire novel research ideas, strengthen international partnerships, and contribute toward the advancement of sustainable, patient-centric, and technology-driven therapeutic strategies for the future.








